FDA celebrates DExEU pay rises of up to 11%

The FDA has secured pay rises of up to 11% for members in the Department for Exiting the European Union (DExEU).
Following talks with the union, the department has offered its staff an average consolidated pay increase of 7.6%, rising to up to 11% for those on the bottom of the pay scale.
DExEU have also increased allowances for specialists. Accountants, analysts and economists will receive up to £5,000 in recognition of their skills and experience.
FDA members based in DExEU voted unanimously to accept the pay offer, which was warmly welcomed by National Officer Victoria Jones.
“Civil servants in DExEU are working flat out to deliver the will of the Government ahead of the UK leaving the EU and deserve every penny of this pay rise,” she said, “which comes after almost 10 years of wage stagnation.”
Jones then called on other government departments to follow DExEU’s example.
“From HMRC to the Home Office,” she explained, “civil servants have risen to the challenge of preparing for Brexit, whatever form it may take, while also ensuring the day to day business of government continues.
“At this crucial time for our country, it is essential that the civil service can recruit and retain the best staff for the job,” Jones continued, “and that can only be achieved if they are paid what they are worth. DExEU has recognised this undeniable fact and it’s high time other departments follow suit.”
Jones’s comments were reported in Civil Service World.
Related News
-

Never again
Following the unacceptable issues arising from the civil service pension scheme transfer to Capita, Adrian Prandle outlines the FDA’s ongoing work to ensure members get the support they need as quickly as possible.
-

Integrated Public Sector Pay and Workforce Policy ‘quietly hard-wires job losses into pay’ creating ‘permanent squeeze’ on staff, says FDA
FDA National Officer for Scotland Allan Sampson has responded to the Integrated Public Sector Pay and Workforce Policy, announced in the 2026 Scottish Budget.
-

FDA calls for rapid improvement following “unacceptable” pension administrator performance
Following the transfer of administration of the civil service pension scheme from MyCSP to Capita at the end of last year, the FDA continue to hear from hundreds of current and retired members who are continuing to be impacted by service levels.